Screening for Gestational Diabetes during the COVID-19 Pandemic—Current Recommendations and Their Consequences
| Autor: | Nicolae Gică, Maria Popa, Irina Duta, Gheorghe Peltecu, Anca Maria Panaitescu, Anca Marina Ciobanu, Alina Veduta |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Medicine (General)
medicine.medical_specialty Complications of pregnancy endocrine system diseases Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Context (language use) Review R5-920 Pregnancy Pandemic Screening programs Humans Mass Screening risk factors Medicine guidelines Intensive care medicine Pandemics SARS-CoV-2 business.industry screening COVID-19 nutritional and metabolic diseases General Medicine medicine.disease gestational diabetes mellitus Gestational diabetes Perinatal morbidity Diabetes Gestational impact Female business |
| Zdroj: | Medicina, Vol 57, Iss 381, p 381 (2021) Medicina |
| ISSN: | 1648-9144 |
| Popis: | Gestational diabetes mellitus (GDM) is recognized as one of the most common medical complications of pregnancy that can lead to significant short-term and long-term risks for the mother and the fetus if not detected early and treated appropriately. Current evidence suggests that, with the use of appropriate screening programs for GDM, those women diagnosed and treated have reduced perinatal morbidity. It has been implied that, when screening for GDM, there should be uniformity in the testing used and in further management. This paper summarizes and compares current screening strategies proposed by international bodies and discusses application in the context of the COVID-19 pandemic. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|